Home >Newsletters >August 1996
 
ASA NEWSLETTER
 
 
August 1996
Volume 60
Number 8
 

Basic Mechanisms of Pain: Cellular and Molecular Aspects

Gudarz Davar, M.D.


Pain is a common symptom in a variety of neurologic diseases. Frequently, pain is due to tissue injury, but in some instances, damage to peripheral or central somatosensory pathways can result in persistent pain that is referred to the deafferented regions of the body surface. For example, in humans, damage to peripheral nerves can produce persistent pain that is resistant to treatment with analgesic drugs, including morphine. In animals, damage to peripheral somatosensory nerves leads to the development of stimulus-evoked behaviors that suggest that the animal is suffering from experimental neuropathic pain.

The mechanisms underlying neuropathic pain in humans and the experimental counterpart in animals are not known in detail, but some of the determining factors have become evident. These include abnormalities in the central nervous system such as "central sensitization" as well as abnormalities in the peripheral nervous system, including alterations in peripheral target tissue (especially inflammation) and abnormal excitability of primary afferent neurons (both nociceptors and low-threshold afferents). This article is focused primarily on the third of these potential mechanisms.

Behavioral Models

Most current efforts at identifying the primary factors involved in the generation of neuropathic hyperexcitability have adopted as a research model somatic nerves innervating the hind limb, specifically, complete and partial injury to the rat sciatic or spinal nerves. These injuries are associated with evidence of stimulus-evoked behaviors that may be indicative of an experimental painful neuropathy. Such behavioral changes may be the result of ectopic spontaneous discharges in primary afferents generated at the injury site or at the level of the dorsal root ganglion. Spontaneous firing in primary afferents can be generated within demyelinated portions of injured axons and may be due to structural alterations of the axon membrane, ectopic autorhythmic firing or abnormal cross-excitation of high-threshold mechanoreceptors by activity in large myelinated regenerating afferents.

The mechanisms underlying this hyperexcitability are not known but could be partially the result of changes in the regulation of receptors such as adrenoreceptors that are involved in the modulation of pain transmission in the periphery. Alternately, primary afferent hyperexcitability that follows injury to somatosensory nerves in animals could be due to changes in the normal distribution or expression of transmembrane proteins that serve as regulated channels for ion flow.

Mechanisms of Hyperexcitability

This article will focus on two families of molecules whose regulation is expected to be centrally involved in abnormal excitability in primary afferent neurons. The first involves excitatory modulation (adrenoreceptors), and the second involves the primary excitability of the neuron (the voltage-sensitive sodium channel).

Adrenoreceptors: Hyperexcitability in primary afferents may be the result of changes in the level of expression or distribution of cell-surface receptors that contribute to the modulation of excitability in primary afferent neurons. Some classes of alpha-adrenergic receptors are present on dorsal root ganglion neurons, and indeed, preliminary data suggest that there may be increases in the surface density, or upregulation, of alpha2 adrenoreceptors in primary afferent neurons after partial nerve injury. Alpha-adrenergic receptors are known to mediate the excitatory effects on injured sensory neurons of activating postganglionic sympathetic efferents and hence may be important in understanding sympathetic-related pain states. Nerve injury triggers massive sprouting of sympathetic fibers at the injury site. Moreover, it has been found recently that sympathetic sprouting is also triggered within dorsal root ganglia after nerve injury. Thus, the substrate for sympathetic-to-sensory coupling is augmented on both the afferent and the efferent limb. This pathophysiological coupling may account for the efficacy of locally or systemically applied alpha-adrenergic antagonists and of sympatholysis in a subset of patients with nerve injury-associated pain. It may also partly explain the observation that such pain is exacerbated by sympathetic efferent activity in some patients, e.g., micturition-associated pain in amputees.

The Voltage-Sensitive Sodium Channel: The voltage-sensitive sodium channel is an ion channel essential for electrical excitability in afferent neurons. Computer simulations show that the threshold for neuronal firing is highly sensitive to sodium channel density at the site of impulse initiation (electrogenesis). A small addition of sodium channels can shift an afferent fiber into a state of hyperexcitability and even yield spontaneous discharge. It has been demonstrated recently using channel localization studies (including immunolocalization) and the sodium channel-specific ligand, tetrodotoxin, that sodium channels indeed accumulate in the axon membrane at sites of nerve injury. Moreover, ectopic hyperexcitability in injured nerves and the neuropathic pain that accompanies it are transiently suppressed by a range of sodium channel antagonists. The regulation of sodium channel synthesis and of membrane insertion are only poorly understood at present. However, it is known that mRNA for at least one type of sodium channel gene (brain type III) appears to be upregulated in primary sensory neurons following peripheral nerve injury in adult rats. The changes in expression of sodium channels in primary afferents following constriction injury, and possible correlations with behavioral hypersensitivity, have just begun to be investigated and clearly warrant further exploration.

Summary

Evidence of regulated expression of adrenoreceptors or sodium channels in primary afferent neurons can help establish a potential role for these molecules in the pathophysiology of experimental neuropathic pain. Specifically, such changes may permit inferences to be made about the contribution of these membrane-related activities to behavioral hyperalgesia and could therefore direct electrophysiologic and other investigations into the mechanisms of primary afferent hyperexcitability.

More significantly, if similar findings are identified in humans, this could lead to the development of better and more selective drugs, targeted at adrenoreceptors or sodium channels, which could be used to treat disabling painful neuropathy.

Bibliography:

Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988; 33:87-107.

Davar G, Maciewicz RJ. Deafferentation pain syndromes. Neurol Clin. 1989; 7:289-304.

Devor M. The pathophysiology of damaged peripheral nerves. In: Wall PD, Melzack R, eds. Textbook of Pain, 3rd Edition. London: Churchill-Livingston; 1994:79-100.

Devor M, Basbaum AI, Bennett GJ, et al. Mechanisms of neuropathic pain following peripheral injury. In: Basbaum AI, Besson JM, eds. Towards a New Pharmacology of Pain. Dahlem Konferenzen, Wiley, Chichester; 1991:417-440.

Devor M, Lomazov P, Matzner O. Na+ channel accumulation in injured axons as a substrate for neuropathic pain. In: Boivie J, Hansson P, Lindblom U, eds. Touch, Temperature and Pain in Health and Disease. Wenner-Gren Center Foundation Symposia. Seattle: IASP Press; 1994. In press.

Kajander KC, Wakisaka S, Bennett GJ. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful neuropathy in the rat. Neurosci Lett. 1992; 135:225-228.

McLachlan EM, Janig W, Devor M, et al. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature. 1993; 363:543-545.

Nicholas A, Pieribone V, Hokfelt T. Distributions of mRNAs for alpha2 adrenergic receptor subtypes in rat brain: An in situ hybridization study. J Comparative Neurol. 1993; 328:575-594.

Wall PD, Devor M, Inbal R, et al. Autotomy following peripheral nerve lesions: Experimental anesthesia dolorosa. Pain. 1979; 7:103-113.

Waxman SG, Kocsis JD, Black JA. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is expressed followed axotomy. J Neurophysiol. 1994; 72:466-470.

This article with a complete set of references is available from the author on request.

Gudarz Davar, M.D., is an Instructor in Anesthesia (Neuroscience) at Harvard Medical School and Associate Anesthesiologist at Brigham and Women's Hospital, Boston, Massachusetts.

 


return to top


 


FEATURES

Molecular Biology and Anesthesiology

ARTICLES


DEPARTMENTS


The views expressed herein are those of the authors and do not necessarily represent or reflect the views, policies or actions of the American Society of Anesthesiologists.

NL Archives

Information for Authors